BHC
Price
$7.58
Change
-$0.21 (-2.70%)
Updated
Aug 20 closing price
Capitalization
2.89B
70 days until earnings call
ZTS
Price
$156.76
Change
+$1.09 (+0.70%)
Updated
Aug 20 closing price
Capitalization
68.99B
70 days until earnings call
Interact to see
Advertisement

BHC vs ZTS

Header iconBHC vs ZTS Comparison
Open Charts BHC vs ZTSBanner chart's image
Bausch Health Companies
Price$7.58
Change-$0.21 (-2.70%)
Volume$2.24M
Capitalization2.89B
ZOETIS
Price$156.76
Change+$1.09 (+0.70%)
Volume$3.05M
Capitalization68.99B
BHC vs ZTS Comparison Chart in %
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. ZTS commentary
Aug 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 21, 2025
Stock price -- (BHC: $7.79 vs. ZTS: $155.67)
Brand notoriety: BHC and ZTS are both notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BHC: 97% vs. ZTS: 78%
Market capitalization -- BHC: $2.89B vs. ZTS: $68.99B
BHC [@Pharmaceuticals: Generic] is valued at $2.89B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $68.99B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.99B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, BHC is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 6 bullish TA indicator(s).

  • BHC’s TA Score: 5 bullish, 5 bearish.
  • ZTS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than BHC.

Price Growth

BHC (@Pharmaceuticals: Generic) experienced а +11.29% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +3.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.99%. For the same industry, the average monthly price growth was +9.96%, and the average quarterly price growth was +71.77%.

Reported Earning Dates

BHC is expected to report earnings on Oct 30, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.99% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($69B) has a higher market cap than BHC($2.89B). BHC has higher P/E ratio than ZTS: BHC (29.96) vs ZTS (26.79). BHC YTD gains are higher at: -3.350 vs. ZTS (-3.522). ZTS has higher annual earnings (EBITDA): 4.02B vs. BHC (3B). BHC has more cash in the bank: 1.73B vs. ZTS (1.44B). ZTS has less debt than BHC: ZTS (6.79B) vs BHC (21.7B). BHC (9.86B) and ZTS (9.39B) have equivalent revenues.
BHCZTSBHC / ZTS
Capitalization2.89B69B4%
EBITDA3B4.02B75%
Gain YTD-3.350-3.52295%
P/E Ratio29.9626.79112%
Revenue9.86B9.39B105%
Total Cash1.73B1.44B120%
Total Debt21.7B6.79B320%
FUNDAMENTALS RATINGS
BHC vs ZTS: Fundamental Ratings
BHC
ZTS
OUTLOOK RATING
1..100
2620
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
10019
PRICE GROWTH RATING
1..100
3858
P/E GROWTH RATING
1..100
2282
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (35) in the Pharmaceuticals Other industry is in the same range as ZTS (35) in the Pharmaceuticals Generic industry. This means that BHC’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (85) in the Pharmaceuticals Generic industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to BHC’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is significantly better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew significantly faster than BHC’s over the last 12 months.

BHC's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as ZTS (58) in the Pharmaceuticals Generic industry. This means that BHC’s stock grew similarly to ZTS’s over the last 12 months.

BHC's P/E Growth Rating (22) in the Pharmaceuticals Other industry is somewhat better than the same rating for ZTS (82) in the Pharmaceuticals Generic industry. This means that BHC’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCZTS
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
66%
Momentum
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
59%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
61%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
57%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 1 day ago
56%
Declines
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 21 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSQO20.680.02
+0.12%
Palmer Square Credit Opportunities ETF
VIS289.650.17
+0.06%
Vanguard Industrials ETF
OALC33.43-0.21
-0.64%
OneAscent Large Cap Core ETF
BBSC69.68-0.49
-0.70%
JPMorgan BetaBuilders US Sml Cp Eq ETF
PEZ99.52-0.88
-0.87%
Invesco DW Consumer Cyclicals Momt ETF

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+2.20%
ELAN - ZTS
45%
Loosely correlated
-1.02%
VTRS - ZTS
44%
Loosely correlated
+0.47%
PAHC - ZTS
41%
Loosely correlated
+1.92%
HLN - ZTS
38%
Loosely correlated
+0.62%
AMRX - ZTS
37%
Loosely correlated
+0.76%
More